Advertisement

China SXT Pharmaceuticals, Inc. SXTC

Set alert

Price alert · SXTC

All alert types
3.25 USD -0.30 -8.45%

At close · Oct 30

3.15 -0.10 -3.08%

After hours · Oct 30, 7:18 PM ET

Bid
3.20 × 1
Ask
3.30 × 1
3.08 Day range 3.50
3.25 52-week range 2,400,000.00
YTD
-100.00%
1 year
-100.00%
Open
3.35
Prev close
3.55
Mkt cap
336.62K
Vol
108.67K
Avg vol
222.67K
EPS
-73,040.00
P/E
0.00
Div yield
0.00%
More statistics
Low
3.08
High
3.50
Forward P/E
0.00
Beta
1.16
Short ratio
0.52
Inst. own
1.35%
Dividend
0.00
Ex-div date
50-d avg
0.47092
200-d avg
0.939895
1y target
0.00

2Y chart

Chart tools
Interval

Events in this range
  • Feb 25, 2025Split: 1 for 8
  • Feb 3, 2026Split: 1 for 150
  • Aug 10, 2026Split: 1 for 80
  • Oct 26, 2026Split: 1 for 100
Signals (80)
NameDateAgo
RSI: OversoldOct 8, 20263 weeks ago
MACD: Buy SignalAug 12, 20262 months ago
RSI: OversoldJul 23, 20263 months ago
SMA: BearishJul 22, 20263 months ago
MACD: Sell SignalJul 17, 20263 months ago
SMA: BullishJun 11, 20264 months ago
RSI: OversoldMay 12, 20265 months ago
RSI: OversoldMay 7, 20265 months ago
SMA: BearishMay 5, 20265 months ago
SMA: BullishApr 20, 20266 months ago
SMA: BearishApr 14, 20266 months ago
SMA: BullishApr 13, 20266 months ago
MACD: Buy SignalFeb 2, 20269 months ago
MACD: Sell SignalJan 9, 20269 months ago
RSI: OversoldJan 9, 20269 months ago
SMA: BearishJan 8, 20269 months ago
SMA: BearishJan 8, 20269 months ago
SMA: BullishJan 7, 20269 months ago
RSI: OverboughtJan 7, 20269 months ago
SMA: BearishJan 6, 20269 months ago
SMA: BullishJan 2, 202610 months ago
SMA: BullishDec 31, 202510 months ago
MACD: Buy SignalDec 31, 202510 months ago
SMA: BearishDec 30, 202510 months ago
MACD: Sell SignalDec 30, 202510 months ago
SMA: BullishDec 15, 202510 months ago
SMA: BearishNov 19, 202511 months ago
SMA: BullishNov 18, 202511 months ago
MACD: Buy SignalNov 18, 202511 months ago
MACD: Sell SignalNov 14, 202511 months ago
SMA: BearishNov 6, 202511 months ago
SMA: BullishNov 5, 202512 months ago
MACD: Buy SignalOct 31, 20251 year ago
SMA: BearishOct 8, 20251 year ago
SMA: BullishOct 2, 20251 year ago
SMA: BearishSep 29, 20251 year ago
SMA: BullishSep 26, 20251 year ago
MACD: Sell SignalSep 25, 20251 year ago
SMA: BearishSep 24, 20251 year ago
SMA: BearishSep 24, 20251 year ago
SMA: BullishSep 11, 20251 year ago
SMA: BullishSep 11, 20251 year ago
SMA: BearishSep 9, 20251 year ago
SMA: BearishSep 9, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BullishSep 5, 20251 year ago
MACD: Buy SignalSep 5, 20251 year ago
SMA: BearishAug 25, 20251 year ago
MACD: Sell SignalAug 25, 20251 year ago
MACD: Buy SignalAug 8, 20251 year ago
SMA: BearishAug 4, 20251 year ago
SMA: BullishAug 1, 20251 year ago
SMA: BearishJul 23, 20251 year ago
SMA: BullishJul 22, 20251 year ago
SMA: BearishJul 7, 20251 year ago
MACD: Sell SignalJul 7, 20251 year ago
SMA: BullishJul 3, 20251 year ago
SMA: BearishJul 2, 20251 year ago
SMA: BullishJul 1, 20251 year ago
MACD: Buy SignalJul 1, 20251 year ago
MACD: Sell SignalJun 27, 20251 year ago
SMA: BearishJun 25, 20251 year ago
SMA: BullishJun 18, 20251 year ago
SMA: BearishJun 13, 20251 year ago
SMA: BullishJun 6, 20251 year ago
MACD: Buy SignalJun 6, 20251 year ago
MACD: Sell SignalMay 15, 20251 year ago
MACD: Buy SignalApr 28, 20251 year ago
RSI: OversoldApr 16, 20251 year ago
SMA: BearishApr 15, 20251 year ago
MACD: Sell SignalMar 11, 20251 year ago
SMA: BullishFeb 24, 20251 year ago
MACD: Buy SignalFeb 24, 20251 year ago
RSI: OverboughtFeb 24, 20251 year ago
SMA: BearishJan 29, 20251 year ago
SMA: BullishJan 24, 20251 year ago
SMA: BearishJan 22, 20251 year ago
SMA: BullishJan 21, 20251 year ago
MACD: Sell SignalJan 14, 20251 year ago
MACD: Buy SignalDec 24, 20241 year ago

Key statistics

Market cap
1.41M
Enterprise value
-7.26M
Trailing P/E
0.00
Forward P/E
0.00
PEG ratio
0.00
Price / sales
0.73
Price / book
0.06
EPS (TTM)
-3.57
Beta
1.16
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-160.67%
Revenue (TTM)
1.93M
Revenue growth
29.50%
Free cash flow
-1.22M
Total cash
12.07M
Total debt
3.70M
Return on equity
-21.65%
Shares outstanding
4.06M
Short % of float
1.84%
50-day average
0.47092
200-day average
0.939895

Analyst view

Consensus: none

Price target (mean) 0.00

Next earnings

Consensus EPS estimate 0.00.

Earnings history

Financials — quick view

All financials
SXTC Revenue — annual 41
2017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
SXTC Net income — annual -6.21M
2017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026
SXTC EPS — annual -73,040.00
2017-FY 20172018-FY 20182019-FY 20192020-FY 20202021-FY 20212022-FY 20222023-FY 20232024-FY 20242025-FY 20252026-FY 2026

About China SXT Pharmaceuticals, Inc.

China SXT Pharmaceuticals, Inc., a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang. It provides its products under the Suxuantang, Hui Chun Tang, and Tong Ren Tang brands. The company had an end-customer base of pharmaceutical companies, chain pharmacies, and hospitals, as well as pharmaceutical distributors. China SXT Pharmaceuticals, Inc. was founded in 2005 and is headquartered in Taizhou, China.

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Country
China
Website
sxtchina.com

News

Your note

Sign in to keep a note on SXTC — it syncs with the Stock Master app.

Institution ownership

SXTC institution ownership
Holder% heldSharesValueReported
Baader Bank Aktiengesellschaft0.37%15,1615.26KSep 29, 2024
Gsa Capital Partners Llp0.30%12,3004.26KSep 29, 2024
Bank of Montreal /CAN/0.25%10,0003.47KSep 29, 2024
UBS Group AG0.21%8,6783.01KSep 29, 2024
JP Morgan Chase & Company0.01%376130Sep 29, 2024
Acadian Asset Management. LLC0.01%379131Sep 29, 2024

Fund ownership

SXTC fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.00%5418Oct 30, 2023
Advertisement